Ampio Pharmaceuticals
AMPE
#10577
Rank
HK$2.21 M
Marketcap
HK$1.95
Share price
3,233.33%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$132.81. In 2022 the company made an earnings per share (EPS) of -HK$168.98 an increase over its 2021 EPS that were of -HK$210.44.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-20.87%
2022-HK$168.98-19.7%
2021-HK$210.44-0%
2020-HK$210.44-10%
2019-HK$233.83-121.74%
2018HK$1,076-158.23%
2017-HK$1,847119.44%
2016-HK$841.78-41.94%
2015-HK$1,450-18.42%
2014-HK$1,77720.63%
2013-HK$1,47385.29%
2012-HK$795.01-52.11%
2011-HK$1,66044.9%
2010-HK$1,146390%
2009-HK$233.83233.33%
2008-HK$70.15-0%
2007-HK$70.15
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Aerie Pharmaceuticals
AERI
-HK$5.85-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.37-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$49.34-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.80-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$338.58-354.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.41-110.09%๐Ÿ‡บ๐Ÿ‡ธ USA